Yufei Xu, Head of Cancer Driver Biology, Oncology Research at Astellas Pharma, shared on LinkedIn:
“Great few days at the EORTC-NCI-AACR symposium 2026 in Barcelona!
Attended with colleagues from Astellas and showcased our work in multiple posters on KRAS research. Enjoyed the scientific discussions, reconnecting with former colleagues and friends, and seeing lots of exciting developments in cancer research and drug discovery. I learned a lot and am leaving Barcelona with new ideas and inspiration.”
You can also read:
Paolo Tarantino: 40 Years of Antibody-Drug Conjugates at the 2026 EORTC-NCI-AACR Symposium